Indian pharma's rising costs, government intervention sought
Indian pharmaceutical manufacturers are facing a crisis as input costs surge by 200-300 percent, driven by global conflicts disrupting raw material supplies. The Himachal Drug Manufacturers Association is appealing to the government for intervention.
The association has requested emergency price controls on essential inputs and the formation of a crisis task force. This is to mitigate the impact of rising costs and ensure the continued availability of medicines, according to a report in the Economictimes.indiatimes.com.
The surge in costs threatens the viability of smaller pharmaceutical units, potentially impacting the supply chain for critical drugs. The association argues that government intervention is necessary to stabilize the industry and prevent shortages.
The request highlights the vulnerability of the Indian pharmaceutical sector to global supply chain disruptions and the potential need for policy measures to protect domestic manufacturing.
About the Author
